Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
about
Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.Improving the treatment of non-Hodgkin lymphoma with antibody-targeted radionuclides.Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient study.131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modelingTargeted radionuclide therapy.
P2860
Factors affecting 131I-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Factors affecting 131I-Lym-1 p ...... chronic lymphocytic leukemia.
@en
type
label
Factors affecting 131I-Lym-1 p ...... chronic lymphocytic leukemia.
@en
prefLabel
Factors affecting 131I-Lym-1 p ...... chronic lymphocytic leukemia.
@en
P2093
P1476
Factors affecting 131I-Lym-1 p ...... d chronic lymphocytic leukemia
@en
P2093
DeNardo DA
DeNardo GL
DeNardo SJ
Lamborn KR
P304
P407
P577
1999-08-01T00:00:00Z